Literature DB >> 15370114

Desmoplastic melanoma: a diagnostic trap for the unwary.

Stanley W McCarthy1, Richard A Scolyer, A Allan Palmer.   

Abstract

Desmoplastic melanoma (DM) is an uncommon type of spindle cell melanoma in which the malignant cells are separated by collagen fibres or fibrous stroma. DM is prone to misdiagnosis because of unfamiliarity with its often bland appearance and dissimilarity to other conventional types of melanoma. It displays variable cytological atypia, cellularity and stromal fibrosis and more often than not has an accompanying atypical junctional component. Neurotropism is a common associated feature (in at least 30% of cases) and when it occurs such tumours are termed 'desmoplastic neurotropic melanomas' (DNM). The neurotropism may be perineural or intraneural and often extends beyond the desmoplastic component. In addition, some DMs show evidence of neural differentiation ('neural transformation'). DM may also present as a recurrence or occasionally as a metastasis from other types of melanoma. A high index of suspicion and knowledge of its often subtle morphological appearance are necessary to avoid misdiagnosis.

Entities:  

Mesh:

Year:  2004        PMID: 15370114     DOI: 10.1080/00313020412331285336

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  18 in total

1.  Neurotropic melanoma: an analysis of the clinicopathological features, management strategies and survival outcomes for 671 patients treated at a tertiary referral center.

Authors:  Alexander H R Varey; Chris Goumas; Angela M Hong; Graham J Mann; Gerald B Fogarty; Jonathan R Stretch; Robyn P M Saw; Andrew J Spillane; Kerwin F Shannon; Kenneth J Lee; Michael J Quinn; John F Thompson; Richard A Scolyer
Journal:  Mod Pathol       Date:  2017-07-21       Impact factor: 7.842

2.  [Histology of malignant tumors caused by UV light].

Authors:  M Megahed
Journal:  Hautarzt       Date:  2012-10       Impact factor: 0.751

Review 3.  Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care.

Authors:  Richard A Scolyer; Georgina V Long; John F Thompson
Journal:  Mol Oncol       Date:  2011-03-21       Impact factor: 6.603

4.  Roles of adjuvant and salvage radiotherapy for desmoplastic melanoma.

Authors:  Daniel E Oliver; Kirtesh R Patel; Jeffrey Switchenko; Douglas Parker; David H Lawson; Keith A Delman; Ragini R Kudchadkar; Mohammad K Khan
Journal:  Melanoma Res       Date:  2016-02       Impact factor: 3.599

5.  Pitfalls and important issues in the pathologic diagnosis of melanocytic tumors.

Authors:  Stanley W McCarthy; Richard A Scolyer
Journal:  Ochsner J       Date:  2010

6.  [Desmoplastic neurotropic melanoma. Diagnosis and therapeutic procedures for a rare clinical entity].

Authors:  J Hauser; H-H Homann; D Drücke; C Kuhnen; S A Esenwein; H-U Steinau
Journal:  Chirurg       Date:  2006-10       Impact factor: 0.955

7.  Mutational dichotomy in desmoplastic malignant melanoma corroborated by multigene panel analysis.

Authors:  Stephan W Jahn; Karl Kashofer; Iris Halbwedl; Gerlinde Winter; Laila El-Shabrawi-Caelen; Thomas Mentzel; Gerald Hoefler; Bernadette Liegl-Atzwanger
Journal:  Mod Pathol       Date:  2015-03-13       Impact factor: 7.842

8.  High molecular weight-melanoma-associated antigen as a biomarker of desmoplastic melanoma.

Authors:  Yasufumi Goto; Takaaki Arigami; Rajmohan Murali; Richard A Scolyer; Atsushi Tanemura; Minoru Takata; Roderick R Turner; Linhda Nguyen; Tung Nguyen; Donald L Morton; Soldano Ferone; Dave S B Hoon
Journal:  Pigment Cell Melanoma Res       Date:  2009-12-04       Impact factor: 4.693

9.  Desmoplastic melanoma: report of 5 cases.

Authors:  A M Manganoni; C Farisoglio; S Bassissi; D Braga; F Facchetti; M Ungari; P G Calzavara-Pinton
Journal:  Dermatol Res Pract       Date:  2009-11-30

10.  Enhanced immunohistochemical detection of neural infiltration in primary melanoma: is there a clinical value?

Authors:  Patrick Scanlon; Jaiying Tian; Judy Zhong; Ines Silva; Richard Shapiro; Anna Pavlick; Russell Berman; Iman Osman; Farbod Darvishian
Journal:  Hum Pathol       Date:  2014-04-18       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.